Wright A, Lin G, Whittington M, McKenna A, Raymond F, Rind D
J Manag Care Spec Pharm. 2024; 30(11):1338-1342.
PMID: 39471267
PMC: 11522443.
DOI: 10.18553/jmcp.2024.30.11.1338.
Schaeffer M, Louvaris Z, Rodrigues A, Poddighe D, Gayan-Ramirez G, Gojevic T
ERJ Open Res. 2023; 9(5).
PMID: 37868146
PMC: 10588797.
DOI: 10.1183/23120541.00300-2023.
Meng W, Zeng H, Zhao Z, Xiong R, Chen Y, Li Z
Sci Rep. 2023; 13(1):16954.
PMID: 37805617
PMC: 10560244.
DOI: 10.1038/s41598-023-44188-2.
Kerwin E, Jones P, Bjermer L, Maltais F, Boucot I, Naya I
Chron Respir Dis. 2023; 20:14799731231202257.
PMID: 37800633
PMC: 10903204.
DOI: 10.1177/14799731231202257.
Rochester C, Alison J, Carlin B, Jenkins A, Cox N, Bauldoff G
Am J Respir Crit Care Med. 2023; 208(4):e7-e26.
PMID: 37581410
PMC: 10449064.
DOI: 10.1164/rccm.202306-1066ST.
Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD.
Donohue J, Rheault T, MacDonald-Berko M, Bengtsson T, Rickard K
Int J Chron Obstruct Pulmon Dis. 2023; 18:1611-1622.
PMID: 37533771
PMC: 10392818.
DOI: 10.2147/COPD.S413436.
Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials).
Anzueto A, Barjaktarevic I, Siler T, Rheault T, Bengtsson T, Rickard K
Am J Respir Crit Care Med. 2023; 208(4):406-416.
PMID: 37364283
PMC: 10449067.
DOI: 10.1164/rccm.202306-0944OC.
Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD).
Ammous O, Feki W, Lotfi T, Khamis A, Gosselink R, Rebai A
Cochrane Database Syst Rev. 2023; 1:CD013778.
PMID: 36606682
PMC: 9817429.
DOI: 10.1002/14651858.CD013778.pub2.
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.
Han M, Ye W, Wang D, White E, Arjomandi M, Barjaktarevic I
N Engl J Med. 2022; 387(13):1173-1184.
PMID: 36066078
PMC: 9741866.
DOI: 10.1056/NEJMoa2204752.
Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings.
Siddharthan T, Pollard S, Quaderi S, Rykiel N, Wosu A, Alupo P
JAMA. 2022; 327(2):151-160.
PMID: 35015039
PMC: 8753498.
DOI: 10.1001/jama.2021.23065.
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial.
Vogelmeier C, Jones P, Kerwin E, Boucot I, Maltais F, Tombs L
Respir Res. 2021; 22(1):279.
PMID: 34711232
PMC: 8555352.
DOI: 10.1186/s12931-021-01859-w.
Health Related Quality of Life in Interstitial Lung Disease: Can We Use the Same Concepts Around the World?.
Aronson K, Suzuki A
Front Med (Lausanne). 2021; 8:745908.
PMID: 34692737
PMC: 8526733.
DOI: 10.3389/fmed.2021.745908.
Efficacy and cardiovascular safety of LAMA in patients with COPD: a systematic review and meta-analysis.
Zhang C, Zhang M, Wang Y, Xiong H, Huang Q, Shuai T
J Investig Med. 2021; 69(8):1391-1398.
PMID: 34362778
PMC: 8639957.
DOI: 10.1136/jim-2021-001931.
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial.
Bjermer L, Boucot I, Vogelmeier C, Maltais F, Jones P, Tombs L
Adv Ther. 2021; 38(9):4815-4835.
PMID: 34347255
PMC: 8408076.
DOI: 10.1007/s12325-021-01855-y.
The Effectiveness of 3 Combined Therapeutic Regimens in Egyptian Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Randomized Double-Blind Prospective Pilot Study.
Mostafa T, El-Azab G, Atia G, Lotfy N
Curr Ther Res Clin Exp. 2021; 94:100625.
PMID: 34306265
PMC: 8296082.
DOI: 10.1016/j.curtheres.2021.100625.
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement.
Aronson K, Danoff S, Russell A, Ryerson C, Suzuki A, Wijsenbeek M
Am J Respir Crit Care Med. 2021; 204(2):e3-e23.
PMID: 34283696
PMC: 8650796.
DOI: 10.1164/rccm.202105-1193ST.
Pain in Veterans with COPD: relationship with physical activity and exercise capacity.
Raphaely R, Mongiardo M, Goldstein R, Robinson S, Wan E, Moy M
BMC Pulm Med. 2021; 21(1):238.
PMID: 34266401
PMC: 8280683.
DOI: 10.1186/s12890-021-01601-8.
How to Assess Breathlessness in Chronic Obstructive Pulmonary Disease.
Lewthwaite H, Jensen D, Ekstrom M
Int J Chron Obstruct Pulmon Dis. 2021; 16:1581-1598.
PMID: 34113091
PMC: 8184148.
DOI: 10.2147/COPD.S277523.
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?.
Kalluri M, Luppi F, Vancheri A, Vancheri C, Balestro E, Varone F
Eur Respir Rev. 2021; 30(160).
PMID: 34039675
PMC: 9488962.
DOI: 10.1183/16000617.0026-2021.
Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge.
Todt B, Szlejf C, Duim E, Linhares A, Kogiso D, Varela G
Respir Med. 2021; 184:106453.
PMID: 34010740
PMC: 8116128.
DOI: 10.1016/j.rmed.2021.106453.